| Position | Action |
|---|---|
| Beat-and-raise with raised buyback + stock holds 10 EMA | Add 1/3 target weight at $155-156 |
| Beat but sells the news | Hold core, look to add on retest of 10 EMA |
| Miss or in-line + stock breaks 10 EMA with volume | Hold core, let hedge do its job, reassess at 50 SMA ($146.54) |
| AR stays elevated above $55B or extends further | Reduce exposure regardless of headline EPS |
XOM presents a compelling risk-adjusted opportunity at $156.97, with technicals confirming a structural uptrend, Q2 earnings set toInflect from Q1's trough, geopolitical crude premiums providing durable tailwinds, and natural gas/LNG exposure adding multi-quarter upside that remains underpriced in the 14.82x forward P/E multiple.
| Indicator | Value | Signal |
|---|---|---|
| Close | $156.97 | neutral |
| 10 EMA | 153.28 | bullish |
| 50 SMA | 146.54 | bullish |
| 200 SMA | 137.80 | bullish |
| RSI(14) | 67.16 | bullish |
| MACD Line | +3.64 | bullish |
| MACD Signal | +2.40 | bullish |
| MACD Histogram | +1.24 | bullish |
| Bollinger Upper | $162.07 | neutral |
| Bollinger Middle | $147.50 | neutral |
| Bollinger Lower | $132.92 | neutral |
This report is AI-generated for informational and educational purposes only and is not investment advice or a recommendation to buy or sell any security. Full disclaimer.
Maintain XOM Exposure Through Q2 Binary Catalyst with 4% Tail Hedge
Hold XOM with 4% tail hedge in Aug $155 puts (deeper than trader's $150 strike to capture higher-probability left-tail scenario to $148-153). Tighten stops to $150.50. The real asymmetry lives in guidance and capital allocation commentary, not the headline EPS number. Execute pre-defined decision tree rather than discretionary sizing in print volatility.
When: EPS miss or in-line + 10 EMA breaks with volume
Then: Hold core, reassess at 50 SMA ($146.54)
· concedes: Q1 2026 was genuinely weak — net income down 45.8% YoY and gross margin compressed to 16.7%; Net debt did rise 91% YoY during the trough quarter; BofA downgrade represents a valid relative-value rotation call preferring CVX over XOM; Light volume day (8.0M shares) could signal insufficient conviction for immediate breakout
The "textbook bullish setup" is a trap: Q1 fundamentals are structurally weak (not cyclically troughed), the receivables explosion signals balance sheet deterioration, the geopolitical premium is priced to fade, and the bar for Q2 earnings is impossibly high with asymmetric downside risk. SELL or HEDGE into the binary catalyst.
→ vs conservative: RSI at 67 and upper Bollinger Band do not constitute overbought conditions; May correction comparison is lazy pattern-matching ignoring current MACD strength at plus 3.64 and 7% crude spike on developing geopolitical event
→ vs conservative: Polymarket data cited is stale relative to July 29 Iran attack and has not repriced Damietta port strike, Jordan missile interceptions, or U.S. response; using pre-event data demonstrates anchoring bias
→ vs neutral: OCF shortfall of ~$0.5B in Q1 is a working capital and timing issue, not structural solvency issue; $83B revenue quarter and 40+ year dividend track record contradict solvency narrative
→ vs neutral: BofA downgrade represents quarter-end rotation to CVX rather than abandoning integrated energy sector; prior buy rating was low conviction and easily reversed by six-week rotation
→ vs neutral: 'Crowded long' thesis contradicted by minimal retail presence; Reddit is silent, StockTwits returned error, no euphoria to unwind at current levels
| ATR(14) | $3.65 | neutral |
| VWMA | $150.68 | bullish |
| Volume | 8.0M | neutral |
Support: 153.28 · 147.5 · 146.54 · 145 · 132.92 | Resistance: 162.07 · 166.35 · 170.3 · 175.22
XOM is in a confirmed medium-term uptrend with price holding above all key moving averages; the 10 EMA ($153.28) and 50 SMA ($146.54) provide layered support, while the upper Bollinger Band at $162.07 is the immediate resistance target. RSI approaching overbought (67.16) warrants caution near current levels, and today's below-average volume (8.0M vs 13.6M average) suggests a pullback entry is preferred for new positions. HOLD / Tactical BUY on pullbacks to the 10 EMA zone with stop below $146.54.
Market Cap
$650.6B
52-Week Range
$105.53 – $176.41
TTM P/E
26.43x
Forward P/E
14.82x
PEG Ratio
1.33
P/B
2.56x
Dividend Yield
2.63%
Beta
0.162
50-Day Avg
$146.61
200-Day Avg
$138.71
Implied Price
$156.94
Q1 2026 Revenue
$83.16B
Q1 2026 Net Income
$4.18B
Q1 2026 Diluted EPS
$1.00
Q1 2026 YoY NI Change
-45.8%
Gross Margin TTM
~29.8%
Gross Margin Q1 2026
16.7%
Operating Margin TTM
6.36%
Profit Margin TTM
7.76%
EBITDA TTM
$56.0B
Total Assets
$464.4B
Total Equity
$254.4B
Total Debt
$47.7B
Cash
$8.4B
Net Debt
$39.2B
Net Debt YoY Change
+91%
Current Ratio
1.04
Working Capital
$3.4B
Working Capital QoQ Change
-80%
Q1 2026 OCF
$8.71B
Q1 2026 CapEx
$6.47B
Q1 2026 FCF
$2.24B
Q1 2026 Dividends
$4.33B
Q1 2026 Buybacks
$4.87B
ROE
9.87%
ROA
4.22%
Gross Profit TTM
$97.0B
Net Income TTM
$25.3B
Effective Tax Rate Q1 2026
35.8%
Receivables
$61.8B
New Debt Issued Q1 2026
$9.97B
Strengths
Concerns
ExxonMobil presents a challenging fundamental picture with Q1 2026 earnings collapsing 46% YoY to $4.18B despite stable $83.16B revenue, driven by severe gross margin compression from 23% (Q1 2025) to 16.7%. The most critical concern is the shift to debt-funded capital returns — for the first time in the visible period, total capital returns ($9.20B) exceeded operating cash flow ($8.71B), prompting $9.97B in new debt issuance and causing net debt to surge 91% YoY to $39.2B. Liquidity metrics are deteriorating with working capital down 80% to $3.4B and current ratio tightening to 1.04, while ROE of 9.87% remains below the cost of equity. The market is pricing in substantial recovery (forward P/E 14.8x vs trailing 26.4x), but Q1 2026 results suggest this recovery has not yet materialized, and the current capital return pace is unsustainable without commodity price recovery.